Separately, Goldman Sachs Group reiterated a buy rating on shares of Novo Nordisk A/S in a research note on Wednesday.
NOVOB remained flat at $€47.79 ($55.57) during trading hours on Friday. Novo Nordisk A/S has a 1-year low of €33.43 ($38.87) and a 1-year high of €56.35 ($65.52).
Featured Article: What does EPS mean?
Receive News & Ratings for Novo Nordisk A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novo Nordisk A/S and related companies with MarketBeat.com's FREE daily email newsletter.